DEPARTMENT OF THE NAVY
OFFICE OF THE SECRETARY
1000 NAVY PENTAGON
WASHINGTON, D.C. 20350-1000
SECNAVINST 5300.30F
ASN (M&RA)
27 Dec 2018
SECNAV INSTRUCTION 5300.30F
From: Secretary of the Navy
Subj: MANAGEMENT OF HUMAN IMMUNODEFICIENCY VIRUS, HEPATITIS B
VIRUS, AND HEPATITIS C VIRUS INFECTION IN THE NAVY AND
MARINE CORPS
Ref: (a) DoD Instruction 6130.03 of 6 May 2018
(b) DoD Instruction 6025.18 of 2 December 2009
(c) DoD Directive 6490.02E of 8 February 2012
(d) DoD Instruction 1332.18 of 5 August 2014
(e) DoD Instruction 1010.10 of 28 April 2014
(f) DoD Instruction 6485.01 of 7 June 2013
(g) SECNAVINST 1850.4E
(h) SECNAVINST 5211.5E
(i) SECNAVINST 1920.6C
(j) SECNAV M-5214.1
(k) NAVMED P-117
(l) NAVPERS 15560D
Encl: (1) Responsibilities
(2) Accession Policy
(3) Testing Procedures
(4) Initial Evaluation of Human Immunodeficiency Virus,
Hepatitis B Virus, and Hepatitis C Virus Positive
Personnel
(5) Active Component Retention and Assignment
(6) Active Component Separation
(7) Reserve Component Policy
(8) Medical and Epidemiological Factors
(9) Information Programs
(10) Confidentiality and Disclosure
(11) Limitations on the Uses of Information
(12) Bloodborne Pathogens Counseling Statement
(13) Order to Follow Preventive Medicine Requirements
(14) Acknowledgement
1. Purpose. To revise the Department of the Navy’s (DON)
policy on identification, surveillance, and administration of
military personnel and applicants infected with Human
